Thrombogenicity studies of three different variants of processed bovine pericardium

[1]  Erling Falk,et al.  Pathogenesis of atherosclerosis. , 2006, Journal of the American College of Cardiology.

[2]  K. Cherian,et al.  Technique to process xenogenic tissues for cardiovascular implantation - : A preliminary report , 2006 .

[3]  R. Fei,et al.  P-Selectin-mediated acute inflammation can be blocked by chemically modified heparin, RO-heparin. , 2005, Molecules and cells.

[4]  M. DeRuiter,et al.  Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  M. Hendriks,et al.  Covalently-Bound Heparin Makes Collagen Thromboresistant , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[6]  B. Smith,et al.  The Effects of Heparin, Protamine, and Heparin/Protamine Reversal on Platelet Function Under Conditions of Arterial Shear Stress , 2001, Anesthesia and analgesia.

[7]  H. Suh,et al.  Heparinized bovine pericardium as a novel cardiovascular bioprosthesis. , 2000, Biomaterials.

[8]  P. Kovanen,et al.  Coimmobilized Native Macromolecular Heparin Proteoglycans Strongly Inhibit Platelet-Collagen Interactions in Flowing Blood , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[9]  T. Chandy,et al.  Synergistic effect of released aspirin/heparin for preventing bovine pericardial calcification. , 2000, Artificial organs.

[10]  E. Laemmel,et al.  Heparin immobilized on proteins usable for arterial prosthesis coating: growth inhibition of smooth-muscle cells. , 1998, Journal of biomedical materials research.

[11]  P. Kovanen,et al.  Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Y. Suda,et al.  Structural aspects of heparin responsible for interactions with von Willebrand factor. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[13]  M. Cardillo,et al.  Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[14]  P Böck,et al.  Decreased tissue reaction to bioprosthetic heart valve material after L-glutamic acid treatment. A morphological study. , 1992, Journal of biomedical materials research.

[15]  M. Reidy.  Factors controlling smooth-muscle cell proliferation. , 1992, Archives of pathology & laboratory medicine.

[16]  M E Nimni,et al.  Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks. , 1990, Journal of biomedical materials research.

[17]  A. Clowes,et al.  Mechanisms of healing in synthetic grafts. , 1987, Journal of vascular surgery.

[18]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[19]  W. Roberts,et al.  Structure of bovine parietal pericardium and of unimplanted Ionescu-Shiley pericardial valvular bioprostheses. , 1981, The Journal of thoracic and cardiovascular surgery.

[20]  W. Lewis,et al.  Relationship between anticoagulant activity of heparin and susceptibility to periodate oxidation , 1979, FEBS letters.

[21]  R. Kronenthal,et al.  Medical and surgical applications of collagen. , 1973, International review of connective tissue research.

[22]  David A. Hall,et al.  International review of connective tissue research , 1963 .